Drugs in the making.com
Dr.Shruti Bhat, an Expert in Pharmaceutical industry, brings to you some highlights from current pharma and clinical research news, views and data.
FDA Devising New Guidelines To Expedite Testing, Approval Of Multidrug Regimens.
The Wall Street Journal reported that the FDA is creating new guidelines aimed at expediting the testing and approval process for multidrug regimens that include new, experimental drugs for some deadly diseases...
FDA Changing Rules For Testing Tuberculosis Drugs.
Insulin patch is on track for clinical trials.
Phosphagenics Limited’ s TPM (Targeted Penetration Matrix) insulin project should begin human trials in the first half of 2010. For this product, the company has adapted the patch technology that it had developed for its oxycodone program. ...
New Study Aims To Identify Effective Breast Cancer Treatments Quickly.
"Breast cancer researchers say they could cut years off the time required to test new drugs for treating certain kinds of tumors under a study about to begin at the University of Minnesota and the Mayo Clinic....
Different Pediatric Asthma Cases Do Best With Different Step-Up Treatments.
Researchers at the University of Wisconsin have discovered that "different kids do best with different step-up treatments" once they find that their "regular steroid inhaler fails to prevent asthma attacks...
Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
Http://www.drshrutibhat.comExpert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.
Do you have questions for the author?
Dr. Shruti Bhat
Pharmaceutical Manufacturing, Continuous Improvement and Business Transformation Consultant
New Release !
The information posted here, not limited to blogs, website, podcasts, videos, eBooks, whitepapers and other 'free' resources including downloaded items are Copyright protected, 'for review' purpose only. Not to be copied, distributed or used without prior written authorization by Dr. Shruti U. Bhat. Any instance(s) found to the contrary would be construed as copyright violation, illegal, plagiarism and/or could be subject to legal proceedings.
For additional details, refer our Terms & Conditions for site usage.
Kaizen book at # 4 on Amazon Best Sellers List!